Search Results

Deals

Amblyotech, A Digital Therapeutics Company, Announces It Has Been Acquired by Novartis

Amblyotech Inc. is a clinical stage digital therapeutics company committed to the advancement of treatments and diagnostics for amblyopia (lazy eye) and other ocular disorders

April 20, 2020

·

2 min read

Amblyotech Release: Create Dig Rush, The First Therapeutic Video Game Based On A Patented Method For The Treatment Of Amblyopia

March 3, 2015

·

4 min read

Bio NC

Revibe Technologies, Maker of a Wearable Device Being Developed for ADHD and Autism, Secures Over $3 Million in Funding, Appoints CEO as Company Enters New Growth Phase

Revibe Technologies today announced they have raised over $3 million in new funding, led by Carolina Angel Network. The new capital will be invested in the clinical and regulatory development of Revibe

April 15, 2021

·

2 min read

Amblyopia Treatment Market: North America to Capture Major Share of Market

Amblyopia, also known as lazy eye disease, commonly affects young children under the age of four. It occurs when the vision in one eye does not develop properly, causing the child to rely on the other, stronger, eye.

December 15, 2020

·

4 min read